COVID-19 Testing Center for Overseas Travelers (TeCOT) to Additionally Start Provision of Services to Short-Term Overseas Business Travelers Having Returned to Japan
October 30, 2020
The COVID-19 Testing Center for Overseas Travelers (TeCOT) is a system in which the government supports business overseas travelers in receiving services for smoothly obtaining a certification for a negative result of a medical test concerning the novel coronavirus disease, a document necessary for entering their destination countries or other purposes. Since its inauguration, TeCOT has only been targeting overseas business travelers who need to undergo a medical test before leaving Japan.
However, in response to the decision by the government of Japan on new measures for resuming cross-border travel, TeCOT will additionally start provision of services concerning medical tests, from November 2 (Mon.), 2020, to short-term overseas business travelers who have returned to or re-entered Japan.
1. Outline of TeCOT
Since October 8 (Thur.), 2020, METI, in collaboration with the Ministry of Health, Labour and Welfare (MHLW), has been operating TeCOT as a system in which overseas business travelers are able to locate and make a reservation at a desired medical institution which provides a medical test for the novel coronavirus and issues a certification for a negative result of the test in a manner tailored to a request from their destination countries.
2. Outline of new measures for addressing resumption of people’s international movement
The government decided to start, from November 1 (Sun.), 2020, new measures targeting Japanese nationals residing in Japan and overseas nationals with the status of residence in Japan in which when they return to or re-enter Japan from their shot-term overseas business trips, they are eligible for a relaxation of the 14-day stay-at-home period following their return to Japan if they satisfy predetermined conditions. In line with this, when such people return to or re-enter Japan from countries or regions falling under Level 2 or lower of the MOFA’s Travel Advice and Warning on Infectious Diseases, such as China, the ROK and Singapore, they are required to: undergo a PCR test or a quantitative antigen test and obtain a certification for a negative result of such a test before leaving Japan to their destination countries or regions; or undergo a PCR test or a quantitative antigen test after having returned to or re-entered Japan.
For details of the measures, visit the websites below.
- Announcement of changes in information on the MOFA’s Travel Advice and Warning on Infectious Diseases and those in procedures involving border controls and other measures (website of the Ministry of Foreign Affairs) (in Japanese)
- Announcement of relaxation of the 14-day stay-at-home period targeting overseas business travelers who reside in Japan (METI website) (in Japanese)(PDF:3,231KB)
3. Start of reservation of medical tests using TeCOT for short-term overseas business travelers who have returned to or re-entered Japan
Against this backdrop, from 13:00, November 2 (Mon.), 2020, TeCOT will start provision of services for short-term overseas business travelers who have returned to or re-entered Japan, supporting them to be are able to locate and make a reservation at a desired medical institution in order to undergo a PCR test or a quantitative antigen test.
Division in Charge
Information on TeCOT:
TeCOT call center (service hours: from 9:00 to 17:00)
For medical institutions:
Tel: 0570-028117 (Line for IP phones, etc.: 03-6830-8026)
For overseas travelers:
Tel: 0570-039656 (Line for IP phones, etc.: 03-6830-8027)
Information on this press release:
Team for Supporting Travelers to Overseas Countries, Investment Facilitation Division, Trade and Economic Cooperation Bureau, METI